番茄社区

Cardiology >

Acute Coronary Syndrome

News, opinions and meeting coverage in cardiology.

ACC: Gout Drug Tames the Heart

WASHINGTON -- Colchicine may be as effective at reducing multiple recurrences of pericarditis as it is in treating acute episodes and first recurrences.

Is There a Flaw in This Large Vitamin D Trial?

A co-principal investigator of the VITAL trial addresses the possibility that out-of-study testing of vitamin D levels and initiation of high-dose supplementation could be a limitation, but not a serious one.

TCT: Removing Clot During PCI Fails in NSTEMI

SAN FRANCISCO -- Aspiration thrombectomy during percutaneous coronary intervention (PCI) did not improve outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI), a randomized trial showed.

Xarelto Gets a No for Stent Thrombosis

SILVER SPRING, Md. -- The FDA has rejected an application for a new indication allowing rivaroxaban (Xarelto) to be used to reduce the risk of stent thrombosis in patients with acute coronary syndrome.

Zilver Stent Recalled, System May Break

Cook Medical's Zilver PTX drug-eluting stent for peripheral artery disease has been recalled because of a defect in its associated delivery system, the company and the FDA said.

Cardio Notes: Stress Test Finds Heart Disease in Seniors

Researchers are taking a second look at the accuracy of treadmill exercise testing for women over 65. Also this week, the birth of a subspecialty for adults with congenital heart disease and leg artery stenting.

FDA Adds Diabetes Warning to Statin Label

WASHINGTON -- The FDA is changing the labeling on statins to include a warning about increased risks of hyperglycemia and transient memory problems, but the agency is no longer recommending routine liver function testing.

Cardiologist Who Revealed Echo Errors Out of a Job

MILWAUKEE -- A cardiologist whose research at a national medical meeting revealed that other doctors at her hospital were misreading a substantial number of diagnostic echocardiograms has been fired by that hospital, the Journal Sentinel and 番茄社区 have learned.

AHA: Rivaroxaban Scores Win While Omega-3 Flops

CHICAGO -- Good news and not so good news about investigational treatments for atrial fibrillation are featured in this exclusive InFocus video report from the American Heart Association meeting.

Canadian Politician Comes to U.S. for Heart Surgery

The top politician in Canada's easternmost province has set off fireworks by deciding to go to the U.S. for heart surgery.

AHA: FDA Drops Clopidogrel Bomb at AHA

ORLANDO -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.

ACP: Garlic, Ginseng, Ginkgo Biloba, and Ginger All Bad Actors with Coumadin

PHILADELPHIA - When it comes to adverse events associated with Coumadin (warfarin) therapy, beware of herbs and many supplements beginning with the letter G, according to a University of Washington investigator.

Morphine for Chest Pain Increases ACS Death Risk

DURHAM, N.C.-Morphine to relieve severe chest pain associated with the non-ST-segment elevation acute coronary syndrome may increase the risk of death by nearly 50%, report Duke investigators. They recommend nitroglycerin as first choice.